OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of GATA3 in the metastasis of triple-negative breast cancer and high-grade serous ovarian cancer
Amr Ahmed El–Arabey, Mohnad Abdalla
Human Cell (2022) Vol. 35, Iss. 4, pp. 1298-1300
Closed Access | Times Cited: 12
Amr Ahmed El–Arabey, Mohnad Abdalla
Human Cell (2022) Vol. 35, Iss. 4, pp. 1298-1300
Closed Access | Times Cited: 12
Showing 12 citing articles:
Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction
Amr Ahmed El–Arabey, Samia S. Alkhalil, Samia T. Al‐Shouli, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 28
Amr Ahmed El–Arabey, Samia S. Alkhalil, Samia T. Al‐Shouli, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 28
Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes in breast cancer patients: a systematic review study
Ali Tayebi, Adnan Tizmaghz, Mahmood Gorjizad, et al.
Journal of Chemotherapy (2025), pp. 1-14
Closed Access
Ali Tayebi, Adnan Tizmaghz, Mahmood Gorjizad, et al.
Journal of Chemotherapy (2025), pp. 1-14
Closed Access
CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway
Wei Liu, Lei Wang, Jiajia Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10652-10652
Open Access | Times Cited: 8
Wei Liu, Lei Wang, Jiajia Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10652-10652
Open Access | Times Cited: 8
siRNA and targeted delivery systems in breast cancer therapy
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 5, pp. 1167-1188
Closed Access | Times Cited: 10
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 5, pp. 1167-1188
Closed Access | Times Cited: 10
Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities
Sara Hadad, Amirreza Khalaji, Amirreza Jabbaripour Sarmadian, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112406-112406
Closed Access | Times Cited: 1
Sara Hadad, Amirreza Khalaji, Amirreza Jabbaripour Sarmadian, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112406-112406
Closed Access | Times Cited: 1
Commentary: Ovarian cancer; path to effective treatments
Anahid Jewett, Sanaz Memarzadeh, Kawaljit Kaur
Critical Reviews in Immunology (2024) Vol. 45, Iss. 1, pp. 93-99
Closed Access | Times Cited: 1
Anahid Jewett, Sanaz Memarzadeh, Kawaljit Kaur
Critical Reviews in Immunology (2024) Vol. 45, Iss. 1, pp. 93-99
Closed Access | Times Cited: 1
ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer
Siyu Liu, Xiaobin Cao, Jing Li, et al.
Biomarkers (2023) Vol. 28, Iss. 5, pp. 437-447
Closed Access | Times Cited: 2
Siyu Liu, Xiaobin Cao, Jing Li, et al.
Biomarkers (2023) Vol. 28, Iss. 5, pp. 437-447
Closed Access | Times Cited: 2
CTLA-4 and ovarian cancer residual tumors: the dark side of debulking surgery
Mohnad Abdalla, Amr Ahmed El–Arabey, Zhongtao Gai
Human Cell (2023) Vol. 36, Iss. 6, pp. 2281-2283
Closed Access | Times Cited: 2
Mohnad Abdalla, Amr Ahmed El–Arabey, Zhongtao Gai
Human Cell (2023) Vol. 36, Iss. 6, pp. 2281-2283
Closed Access | Times Cited: 2
Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
Shi‐Tang Ma, Ning Zhang, Jiafu Hou, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 3
Shi‐Tang Ma, Ning Zhang, Jiafu Hou, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 3
Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy
Liaoran Niu, Qi Wang, Fan Feng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166917-166917
Closed Access | Times Cited: 1
Liaoran Niu, Qi Wang, Fan Feng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166917-166917
Closed Access | Times Cited: 1
WITHDRAWN: FUT8-AS1 promotes ovarian cancer progression and invasion via regulation of miR-149-5p/Notch1 axis
Dandan Wu, Jia Liu, Xin Yang, et al.
Heliyon (2023), pp. e18792-e18792
Open Access
Dandan Wu, Jia Liu, Xin Yang, et al.
Heliyon (2023), pp. e18792-e18792
Open Access
